Effectiveness of GLP-1s When You Have Bipolar Do GLP-1s work as well for their FDA-approved uses in people with bipolar disorder as in those without
Accessed November 13, 2024 [21] Shrivastava S, Sharma A, Saxena N, Bhamra R, Kumar S
The cardiovascular safety and efficacy of tirzepatide in adults with T2D has been assessed in a large phase 3 clinical trial (SURPASS-CVOT) (Table 1) [88]
supplements do not Clinical evidence : GLP-1 agonists have extensive randomized controlled trial data
Concerns include: Common side effects of GLP-1 drugs can include nausea, vomiting, diarrhea, and stomach-related issues
Cardiovascular safety of oral semaglutide in patients with type 2 diabetes: Rationale, design and patient baseline characteristics for the PIONEER 6 trial